172
Participants
Start Date
May 31, 2018
Primary Completion Date
June 26, 2024
Study Completion Date
June 26, 2024
FFR-guided PCI and TAVI
Treatment of subjects with multivessel coronary artery disease and aortic stenosis for FFR-guided PCI and TAVI (Medtronic CoreValve Evolut R or Medtronic CoreValve Evolut R PRO)
CABG and SAVR
Treatment of subjects with multivessel coronary artery disease and aortic stenosis for CABG and SAVR
Medical University of Graz, Graz
General Hospital Vienna, Vienna
Rigshospitalet, Copenhagen University Hospital, Copenhagen
CHU de Bordeaux, Bordeaux
CHRU de Lille, Lille
Clinique Pasteur, Toulouse
Universitäres Herz- und Gefäßzentrum UKE Hamburg GmbH, Hamburg
Onassis Cardiac Surgery Center, Kallithea
OLVG, Amsterdam
UMCG, Groningen
St. Antonius hospital, Nieuwegein
Radboudumc, Nijmegen
Hagaziekenhuis, The Hague
Isala hospital, Zwolle
Medical University of Silesia, Katowice
University hospital Opole, Opole
Hospital de Santa Cruz, Lisbon
SUSCCH, Banská Bystrica
Hospital Clinico Universitario San Carlos, Madrid
Hospital Clínico Valladolid, Valladolid
Collaborators (1)
Medtronic
INDUSTRY
Maatschap Cardiologie Zwolle
OTHER